Flash FinanceUS
Market open S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · BrightSpring Health Services (BTSG)

BrightSpring Q4 revenue up 29% to $3.55 billion; initiates 2026 EBITDA guidance

Positive Impact 3 of 5 earnings Written later

BrightSpring reported fourth-quarter 2025 revenue of $3,551 million, up 29.3%, and net income from continuing operations of $49.6 million, up from $4.3 million a year earlier. The company also initiated full-year 2026 revenue guidance of $14,450 million to $15,000 million and Adjusted EBITDA guidance of $760 million to $790 million, both excluding the Community Living business.

Key points

  • Q4 2025 Adjusted EBITDA was $184 million, up 40.7% from $130 million; full-year 2025 Adjusted EBITDA was $618 million, up 34.2%.
  • Full-year 2025 net income from continuing operations was $104.8 million, compared with a net loss of $68.9 million in 2024.
  • Leverage fell to 2.99x at December 31, 2025, from 4.16x a year earlier.
  • The Community Living divestiture to Sevita is expected to close by the end of the first quarter of 2026.

The filing

CompanyBrightSpring Health Services (BTSG)
Form8-K, current report
Filed with the SECFeb 27, 2026, 6:05 AM ET
Accession number0001193125-26-078998

Items reported: 2.02 Results of Operations

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 1:12 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on February 27, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.